These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38541302)

  • 41. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Temporal pattern of tuberculosis cure, mortality, and treatment abandonment in Brazilian capitals.
    Sousa GJB; Garces TS; Pereira MLD; Moreira TMM; Silveira GMD
    Rev Lat Am Enfermagem; 2019; 27():e3218. PubMed ID: 31826160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost-effectiveness analysis of human papillomavirus DNA testing and Pap smear for cervical cancer screening in a publicly financed health-care system.
    Chow IH; Tang CH; You SL; Liao CH; Chu TY; Chen CJ; Chen CA; Pwu RF
    Br J Cancer; 2010 Dec; 103(12):1773-82. PubMed ID: 21102588
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study.
    Syrjänen K; Naud P; Derchain S; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Hammes LS; Matos J; Gontijo R; Sarian L; Braganca J; Arlindo FC; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S
    Anticancer Res; 2005; 25(5):3469-80. PubMed ID: 16101165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
    Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
    Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conventional Pap smear and liquid-based cytology as screening tools in low-resource settings in Latin America: experience of the Latin American screening study.
    Longatto-Filho A; Maeda MY; Erzen M; Branca M; Roteli-Martins C; Naud P; Derchain SF; Hammes L; Matos J; Gontijo R; Sarian LO; Lima TP; Tatti S; Syrjänen S; Syrjänen K
    Acta Cytol; 2005; 49(5):500-6. PubMed ID: 16334026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of COVID-19 in Cervical and Breast Cancer Screening and Systemic Treatment in São Paulo, Brazil: An Interrupted Time Series Analysis.
    Duarte MBO; Argenton JLP; Carvalheira JBC
    JCO Glob Oncol; 2022 Jun; 8():e2100371. PubMed ID: 35696624
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Barriers to cervical cancer screening in women attending the Family Medical Program in Niterói, Rio de Janeiro.
    Augusto EF; Rosa ML; Cavalcanti SM; Oliveira LH
    Arch Gynecol Obstet; 2013 Jan; 287(1):53-8. PubMed ID: 22886356
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Excessive Pap smears due to opportunistic cervical cancer screening.
    Freitas RA; Carvasan GA; Morais SS; Zeferino LC
    Eur J Gynaecol Oncol; 2008; 29(5):479-82. PubMed ID: 19051817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Effect of Disability and Social Determinants of Health on Breast and Cervical Cancer Screenings During the COVID-19 Pandemic.
    Rolle LD; Chery MJ; Larson M; Lopez-Pentecost M; Calfa CJ; Schlumbrecht MP; Crane TE
    Prev Chronic Dis; 2024 Jan; 21():E05. PubMed ID: 38271492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Magnitude of mortality from cervical cancer in the Brazilian Northeast and socioeconomic factors].
    Gamarra CJ; Valente JG; Azevedo e Silva G
    Rev Panam Salud Publica; 2010 Aug; 28(2):100-6. PubMed ID: 20963276
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic damage in exfoliated cells of the uterine cervix. Association and interaction between cigarette smoking and progression to malignant transformation?
    Cerqueira EM; Santoro CL; Donozo NF; Freitas BA; Pereira CA; Bevilacqua RG; Machado-Santelli GM
    Acta Cytol; 1998; 42(3):639-49. PubMed ID: 9622681
    [TBL] [Abstract][Full Text] [Related]  

  • 53. COVID-19 in northeast Brazil: first year of the pandemic and uncertainties to come.
    Kerr LRFS; Kendall C; Almeida RLF; Ichihara MY; Aquino EML; Silva AAMD; Ximenes RAA; Albuquerque MFPM; Almeida-Filho N; Souza RF; Brandão Filho SP; Souza WV; Barreto ML
    Rev Saude Publica; 2021; 55():35. PubMed ID: 34105604
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of financial resources for public health in Brazilian capitals: a time trend ecological study.
    Oliveira VHFP; Oliveira MB; Blumenberg C; Herval ÁM; Paranhos LR
    Cad Saude Publica; 2022; 38(1):e00311620. PubMed ID: 35043888
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation of overweight condition and obesity with mortality by COVID-19 in Brazil's state capitals.
    Carneiro RAVD; Hillesheim D; Hallal ALC
    Arch Endocrinol Metab; 2021 Nov; 65(3):386-391. PubMed ID: 33844897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Economic evaluation of policy options for prevention and control of cervical cancer in Thailand.
    Praditsitthikorn N; Teerawattananon Y; Tantivess S; Limwattananon S; Riewpaiboon A; Chichareon S; Ieumwananonthachai N; Tangcharoensathien V
    Pharmacoeconomics; 2011 Sep; 29(9):781-806. PubMed ID: 21838332
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Repercussions of the COVID-19 pandemic on breast cancer actions in a Brazilian state.
    Dos Santos Dias PD; de Santana ME; de Azevedo Lima VL
    Invest Educ Enferm; 2024 Jun; 42(2):. PubMed ID: 39083831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
    Sarian LO; Derchain SF; Naud P; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Serpa-Hammes L; Matos J; Gontijo R; Bragança JF; Lima TP; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S; Syrjänen K
    J Med Screen; 2005; 12(3):142-9. PubMed ID: 16156945
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cervical cancer-related knowledge, attitudes, and practices of health professionals working in brazil's network of primary care units.
    Stormo AR; de Moura L; Saraiya M
    Oncologist; 2014 Apr; 19(4):375-82. PubMed ID: 24668334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women.
    Assoumou SZ; Mabika BM; Mbiguino AN; Mouallif M; Khattabi A; Ennaji MM
    BMC Womens Health; 2015 Apr; 15():37. PubMed ID: 25924940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.